2012
DOI: 10.1016/j.genm.2011.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Optical Technologies and Molecular Imaging for Cervical Neoplasia: A Program Project Update

Abstract: There is an urgent global need for effective and affordable approaches to cervical cancer screening and diagnosis. For developing nations, cervical malignancies remain the leading cause of cancer death in women. This reality is difficult to accept given that these deaths are largely preventable; where cervical screening programs are implemented, cervical cancer deaths decrease dramatically. In the developed world, the challenges with respect to cervical disease stem from high costs and over-treatment. We are p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 119 publications
0
8
0
Order By: Relevance
“…Participants in this study were those taking part in a larger National Institutes of Health-sponsored clinical trial to evaluate emerging optical technologies for diagnosis of cervical dysplasia [ 22 , 23 ]. The protocol of the parent study (Development and Application of a Multispectral Digital Colposcope and Probe Algorithm for Detection of Cervical Intraepithelial Neoplasia) was reviewed and approved by the TTUHSC Institutional Review Board (IRB) for the Protection of Human Subjects (IRB # E12117).…”
Section: Methodsmentioning
confidence: 99%
“…Participants in this study were those taking part in a larger National Institutes of Health-sponsored clinical trial to evaluate emerging optical technologies for diagnosis of cervical dysplasia [ 22 , 23 ]. The protocol of the parent study (Development and Application of a Multispectral Digital Colposcope and Probe Algorithm for Detection of Cervical Intraepithelial Neoplasia) was reviewed and approved by the TTUHSC Institutional Review Board (IRB) for the Protection of Human Subjects (IRB # E12117).…”
Section: Methodsmentioning
confidence: 99%
“…This study serves as a critical step towards utilizing confocal approaches in an in vivo clinical application. This study was part of an ongoing project with the ultimate goal of integrating advances in cancer biology and optical technology to develop cost-effective tools to aid in early detection of cervical cancer [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, more work needs to be done to assess the true value of this technology in clinical settings. In the lats 10 years, our group has been facing numerous challenges, mostly related to instrumentation, implementation, quality control, and biological variability to implement reflectance and fluorescence spectroscopy in clinic [ 24 ]. We had underestimated the difficulty and complexity of moving optical technology from bench to clinic.…”
Section: Introductionmentioning
confidence: 99%
“…The cases in this analysis represent a subset of participants from a clinical trial to evaluate emerging technologies for the identification of cervical neoplasia [8]. Trial participants included women with abnormal Papanicolaou test screening presenting for colposcopy at one of three participating hospitals in the U.S. (Houston, Texas) and Canada (Vancouver, British Columbia) between 1999 and 2005, as well as community volunteers with no prior history of dysplasia.…”
Section: Methodsmentioning
confidence: 99%